Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Scalzo

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2002
Recognition of a virus-encoded ligand by a natural killer cell activation receptorHamish R C Smith, Jonathan W Heusel, Indira K Mehta, et al.
The Journal of Experimental Medicine|June 2, 2010
Innate immunity defines the capacity of antiviral T cells to limit persistent infectionDaniel M Andrews, Marie J Estcourt, Christopher E Andoniou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1996
Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopesS A Thomson, S L Elliott, M A Sherritt, et al.
Plos One|September 12, 2009
Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growthRobbert G van der Most, Andrew J Currie, Amanda L Cleaver, et al.
Nature Immunology|November 13, 2012
Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cellsDaniel M Andrews, Lucy C Sullivan, Nikola Baschuk, et al.
Nature Immunology|June 29, 2026
Editorial Expression of Concern: Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cellsDaniel M Andrews, Lucy C Sullivan, Nikola Baschuk, et al.
Journal of Functional Biomaterials|April 25, 2022
Catalyst-Free Click Chemistry for Engineering Chondroitin Sulfate-Multiarmed PEG Hydrogels for Skin Tissue EngineeringGustavo F Sousa, Samson Afewerki, Dalton Dittz, et al.
Nanoscale|October 22, 2015
Functionalized nanomaterials: are they effective to perform gene delivery to difficult-to-transfect cells with no cytotoxicity?F M P Tonelli, S M S N Lacerda, N C O Paiva, et al.
Nature Immunology|May 14, 2013
Targeting of a natural killer cell receptor family by a viral immunoevasinRichard Berry, Natasha Ng, Philippa M Saunders, et al.
American Journal of Physiology. Cell Physiology|March 10, 2022
Neuronal cholinergic signaling constrains norepinephrine activity in the heartDiogo A Guimarães, Nayara S S Aquino, Cibele Rocha-Resende, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2002
Recognition of a virus-encoded ligand by a natural killer cell activation receptorHamish R C Smith, Jonathan W Heusel, Indira K Mehta, et al.
The Journal of Experimental Medicine|June 2, 2010
Innate immunity defines the capacity of antiviral T cells to limit persistent infectionDaniel M Andrews, Marie J Estcourt, Christopher E Andoniou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1996
Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopesS A Thomson, S L Elliott, M A Sherritt, et al.
Plos One|September 12, 2009
Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growthRobbert G van der Most, Andrew J Currie, Amanda L Cleaver, et al.
Nature Immunology|November 13, 2012
Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cellsDaniel M Andrews, Lucy C Sullivan, Nikola Baschuk, et al.
Nature Immunology|June 29, 2026
Editorial Expression of Concern: Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cellsDaniel M Andrews, Lucy C Sullivan, Nikola Baschuk, et al.
Journal of Functional Biomaterials|April 25, 2022
Catalyst-Free Click Chemistry for Engineering Chondroitin Sulfate-Multiarmed PEG Hydrogels for Skin Tissue EngineeringGustavo F Sousa, Samson Afewerki, Dalton Dittz, et al.
Nanoscale|October 22, 2015
Functionalized nanomaterials: are they effective to perform gene delivery to difficult-to-transfect cells with no cytotoxicity?F M P Tonelli, S M S N Lacerda, N C O Paiva, et al.
Nature Immunology|May 14, 2013
Targeting of a natural killer cell receptor family by a viral immunoevasinRichard Berry, Natasha Ng, Philippa M Saunders, et al.
American Journal of Physiology. Cell Physiology|March 10, 2022
Neuronal cholinergic signaling constrains norepinephrine activity in the heartDiogo A Guimarães, Nayara S S Aquino, Cibele Rocha-Resende, et al.
Pageof 11